Outlook Therapeutics Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Corporate Update

NEXT STORY
XpresSpa Group™ Receives Approval for a $2 Million Program with the Centers for Disease Control and Prevention (CDC) for Biosurveillance Tracking in Collaboration with Concentric by Ginkgo at Three Major U.S. Airports
PREV STORY
PMV Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Highlights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vaxcyte Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

author_avatar
NASDAQ Market News

Global Respiratory Diseases Drugs Market Report 2021: Major Players are GlaxosmithKline; AstraZeneca; Merck & Co; Novartis and Johnson & Johnson

author_avatar
NASDAQ Market News

Palette Life Sciences Announces Completion of $30 Million Equity Financing and Expansion of the Board of Directors

author_avatar
NASDAQ Market News